SHE:002880 - Shenzhen Weiguang Biological Products Co Ltd

Shenzhen Weiguang Biological P
Sector: Health Care, Industry: Pharmaceuticals

Add to Watchlist

•  Default
• New Watchlist

   

Yahoo Finance (Live Price)

• Summary
• Financials
• Dividend
• Prices
• Posts
• User
• Alerts

Balance Sheet Cash Flow Income Statement Key Ratios Personalized

Show %	2015 Q2	2015 Q4	2016 Q4	2017 Q1	2017 Q2	2017 Q3	2017 Q4	2018 Q1	2018 Q2	2018 Q3	2018 Q4	2019 Q1	2019 Q2	2019 Q3	2019 Q4	2020 Q1	2020 Q2	2020 Q3	2020 Q4	2021 Q1	2021 Q2	2021 Q3	2021 Q4	2022 Q1	2022 Q2	2022 Q3	2022 Q4	2023 Q1	2023 Q2	2023 Q3	2023 Q4	2024 Q1	Graph
Total Assets	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	1.8B 1.4%	1.9B 6.1%	2B 5.2%	2.17B 8.2%	2.39B 10.5%	2.46B 2.7%	2.58B 4.8%	2.66B 3.1%	2.66B 0.0%	2.67B 0.3%	2.88B 7.9%	3.03B 5.4%
Current Assets	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	968.71M -2.9%	988.32M 2.0%	999.36M 1.1%	1.13B 13.1%	1.28B 13.3%	1.28B -0.1%	1.13B -11.4%	1.17B 2.8%	1.14B -1.8%	1.08B -5.7%	1.1B 2.3%	1.26B 14.1%
Cash+Equi+Others	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	298.51M -22.5%	280.1M -6.2%	332.1M 18.6%	432.41M 30.2%	549.75M 27.1%	477.26M -13.2%	294.59M -38.3%	311.17M 5.6%	356.02M 14.4%	192.33M -46.0%	252.3M 31.2%	337.17M 33.6%
NonCurrent Assets	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	827.52M 6.8%	916.63M 10.8%	1B 9.5%	1.04B 3.3%	1.11B 7.4%	1.18B 5.9%	1.44B 22.3%	1.49B 3.3%	1.51B 1.4%	1.59B 4.9%	1.77B 11.7%	1.77B 0.0%
Total Liabilities	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	143.25M 17.9%	184.45M 28.8%	215.23M 16.7%	350.38M 62.8%	601.28M 71.6%	639.77M 6.4%	708.2M 10.7%	743.12M 4.9%	688.18M -7.4%	691.95M 0.5%	831.14M 20.1%	940.83M 13.2%
Current Liabilities	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	117.03M 22.4%	156.79M 34.0%	167.15M 6.6%	120.93M -27.7%	244.6M 102.3%	233.15M -4.7%	229.76M -1.5%	211.56M -7.9%	124.94M -40.9%	167.96M 34.4%	265.99M 58.4%	328.85M 23.6%
NonCurrent Liabilities	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	26.22M 1.1%	27.65M 5.5%	48.08M 73.8%	229.45M 377.3%	356.68M 55.5%	406.61M 14.0%	478.44M 17.7%	531.56M 11.1%	563.24M 6.0%	523.98M -7.0%	565.15M 7.9%	611.98M 8.3%
Total Equity	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	1.65B 0.1%	1.72B 4.1%	1.79B 3.9%	1.82B 1.6%	1.79B -1.3%	1.82B 1.4%	1.87B 2.7%	1.91B 2.4%	1.97B 2.9%	1.97B 0.3%	2.05B 3.7%	2.09B 2.3%
Stockholders Equity	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	1.63B 0.2%	1.7B 4.1%	1.77B 4.0%	1.79B 1.4%	1.77B -1.3%	1.8B 1.5%	1.84B 2.5%	1.89B 2.5%	1.94B 2.9%	1.95B 0.3%	2.01B 3.5%	2.06B 2.3%
Minority Interest	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	19.73M -5.3%	19.55M -0.9%	19.55M 0.0%	22.92M 17.2%	22.99M 0.3%	23.01M 0.1%	26.77M 16.3%	26.61M -0.6%	26.59M -0.1%	26.81M 0.9%	31.36M 17.0%	31.32M -0.1%